Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2019

01-01-2019 | Original Article

Bacteriological profile of sepsis and its correlation with procalcitonin in patients with diabetes mellitus

Authors: Ashwani Kumar, Pawan Sagar, Bineeta Kashyap, S.V. Madhu, Aditi, Nishesh Jain

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2019

Login to get access

Abstract

Bloodstream infections can lead to life-threatening sepsis and require rapid antimicrobial treatment. It is an accepted opinion that diabetes worsens prognosis of infection, particularly sepsis, although there is not much data published on this subject. The aim was to study the bacteriological profile of sepsis in patients of diabetes mellitus (DM) and the correlation of procalcitonin as biomarker of sepsis and blood culture positivity. Study was conducted at University College of Medical Sciences (UCMS) and Guru Teg Bahadur (GTB) Hospital from December 2013 to November 2014. Thirty known diabetic patients with signs and symptoms of sepsis were enrolled for the study irrespective of age, sex, and type of diabetes. Blood samples were taken for blood culture, estimation of procalcitonin and blood glucose levels, fasting and postprandial and glycosylated hemoglobin, and other relevant biochemical tests. Out of the 30 samples, 9 (30%) patients yielded growth; among them, 66.6% were found to be Staphylococcus aureus and 33.3% were Klebsiella pneumoniae. Median procalcitonin (PCT) levels in positive blood culture subjects were significantly higher than those with negative blood culture. We observed blood culture positivity in 30% of the patients of DM with sepsis, predominance of Gram-positive bacteria, and significantly higher PCT levels in blood culture-positive patients.
Literature
1.
go back to reference Knapp S. Diabetes and infection: is there a link?—a mini review. Gerontology. 2013;59(2):99–104.CrossRefPubMed Knapp S. Diabetes and infection: is there a link?—a mini review. Gerontology. 2013;59(2):99–104.CrossRefPubMed
2.
go back to reference Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281–8.CrossRefPubMed Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281–8.CrossRefPubMed
3.
go back to reference Koh GC, Peacock SJ, van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2012;31(4):379–88.CrossRefPubMed Koh GC, Peacock SJ, van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2012;31(4):379–88.CrossRefPubMed
4.
go back to reference Kawahito S, Kitahata H, Oshita S. Problem associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroentrol. 2009;15(33):4137–5142.CrossRef Kawahito S, Kitahata H, Oshita S. Problem associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroentrol. 2009;15(33):4137–5142.CrossRef
5.
go back to reference Weinstein MP. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584–602.CrossRefPubMed Weinstein MP. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584–602.CrossRefPubMed
6.
go back to reference Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396–402.CrossRefPubMed Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396–402.CrossRefPubMed
7.
go back to reference Jin M, Khan AI. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med. 2010;41(3):173–7.CrossRef Jin M, Khan AI. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med. 2010;41(3):173–7.CrossRef
8.
go back to reference Collee JG, Miles RS, Watt B. Tests for identification of bacteria. Mackie & McCartney practical medical microbiology. 14th ed. New York & London: Churchill Livingstone; 1996. p. 131–49. Collee JG, Miles RS, Watt B. Tests for identification of bacteria. Mackie & McCartney practical medical microbiology. 14th ed. New York & London: Churchill Livingstone; 1996. p. 131–49.
9.
go back to reference CLSI. Performance standards for antimicrobial susceptibility testing. 19th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2009. CLSI. Performance standards for antimicrobial susceptibility testing. 19th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
10.
go back to reference Rawat V, Singhai M, Kumar A, Jha PK, Goyal R. Bacterial and resistance profile in isolates from diabetic patients. Am J Med Sci. 2012;4(11):563–8.CrossRef Rawat V, Singhai M, Kumar A, Jha PK, Goyal R. Bacterial and resistance profile in isolates from diabetic patients. Am J Med Sci. 2012;4(11):563–8.CrossRef
11.
go back to reference Jain SK, Barman R. Bacteriological profile of diabetic foot ulcer with special reference to drug-resistant strains in a tertiary care center in North-East India. Indian J Endocrinol Metab. 2017;21(5):688–94.CrossRefPubMedPubMedCentral Jain SK, Barman R. Bacteriological profile of diabetic foot ulcer with special reference to drug-resistant strains in a tertiary care center in North-East India. Indian J Endocrinol Metab. 2017;21(5):688–94.CrossRefPubMedPubMedCentral
12.
go back to reference Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complicat. 2005;19:138–41.CrossRefPubMed Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complicat. 2005;19:138–41.CrossRefPubMed
13.
go back to reference Amini M, Davati A, Piri M. Determination of the resistance pattern of prevalent aerobic bacterial infections of diabetic foot ulcer. Iran J Pathol. 2013;8:21–6. Amini M, Davati A, Piri M. Determination of the resistance pattern of prevalent aerobic bacterial infections of diabetic foot ulcer. Iran J Pathol. 2013;8:21–6.
14.
go back to reference Michalia M, Kompoti M, Koutsikou A, Paridou A, Giannopoulou P, Trikka-Graphakos E, et al. Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med. 2009;35(3):448–54.CrossRefPubMed Michalia M, Kompoti M, Koutsikou A, Paridou A, Giannopoulou P, Trikka-Graphakos E, et al. Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med. 2009;35(3):448–54.CrossRefPubMed
15.
go back to reference Asati DP, Sharma VK, Khandpur S, Khilnani GC, Kapil A. Clinical and bacteriological profile and outcome of sepsis in dermatology ward in tertiary care center in New Delhi. Indian J Dermatol Venereol Leprol. 2011;77:141–7.CrossRefPubMed Asati DP, Sharma VK, Khandpur S, Khilnani GC, Kapil A. Clinical and bacteriological profile and outcome of sepsis in dermatology ward in tertiary care center in New Delhi. Indian J Dermatol Venereol Leprol. 2011;77:141–7.CrossRefPubMed
16.
go back to reference van Nieuwkoop C, Bonten TN, van’tWout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14(6):R206.CrossRefPubMedPubMedCentral van Nieuwkoop C, Bonten TN, van’tWout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14(6):R206.CrossRefPubMedPubMedCentral
17.
go back to reference Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis. 2002;35:156–61.CrossRefPubMed Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis. 2002;35:156–61.CrossRefPubMed
18.
go back to reference Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med [Internet]. 2017;15(1):15.CrossRef Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med [Internet]. 2017;15(1):15.CrossRef
19.
go back to reference Yu Y, Li XX, Jiang LX, Du M, Liu ZG, Cen ZR, et al. Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study. Infect Dis (Lond). 2016;48(1):63–9.CrossRef Yu Y, Li XX, Jiang LX, Du M, Liu ZG, Cen ZR, et al. Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study. Infect Dis (Lond). 2016;48(1):63–9.CrossRef
20.
go back to reference Guo SY, Zhou Y, Hu QF, Yao J, Wang H. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci. 2015;349(6):499–504.CrossRefPubMedPubMedCentral Guo SY, Zhou Y, Hu QF, Yao J, Wang H. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci. 2015;349(6):499–504.CrossRefPubMedPubMedCentral
Metadata
Title
Bacteriological profile of sepsis and its correlation with procalcitonin in patients with diabetes mellitus
Authors
Ashwani Kumar
Pawan Sagar
Bineeta Kashyap
S.V. Madhu
Aditi
Nishesh Jain
Publication date
01-01-2019
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0651-0

Other articles of this Issue 1/2019

International Journal of Diabetes in Developing Countries 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.